QA: Zymeworks Inc in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001937653_2023_Zymeworks_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}
warning Missing logo subcommand.report {}

Graph

Absolute values for 0001937653, Zymeworks Inc

  xvar xval
0 AssetsCurrent 544,706,000
1 IntangibleAssetsNetIncludingGoodwill 20,771,000
2 PropertyPlantAndEquipmentNet 24,713,000
3 remainder_Assets 58,535,000
4 LiabilitiesCurrent 95,625,000
5 LiabilitiesNoncurrent 58,356,000
6 remainder_Liabilities 1,788,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 73,358,000
9 ResearchAndDevelopmentExpense 208,596,000
10 remainder_Expenses 10,893,000
11 remainder_Revenues 412,482,000
12 remainder_NetIncome 4,706,000
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 648,725,000
1 Liabilities 155,769,000
2 Expenses 292,847,000
3 Revenues 412,482,000
4 StockholdersEquity 492,956,000
5 NetIncome 124,341,000
6 ComprehensiveNetIncome 124,341,000
7 BaseVar 757,264,500
8 EconomicCapitalRatiobeforeLimitedLiability 2.98
9 EconomicCapitalRatio 3.67

Edgar->Model Mapping

Feature Distribution